Cencora, Inc.

NYSE:COR Lagerbericht

Marktkapitalisierung: US$47.7b

Cencora Management

Management Kriterienprüfungen 3/4

Cencora CEO ist Bob Mauch , ernannt in Oct 2022, hat eine Amtszeit von 2.08 Jahren. Die jährliche Gesamtvergütung beträgt $7.70M , bestehend aus 12.7% Gehalt und 87.3% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 0.016% der Aktien des Unternehmens, im Wert von $7.56M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 2.5 Jahre bzw. 9.5 Jahre.

Wichtige Informationen

Bob Mauch

Geschäftsführender

US$7.7m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts12.7%
Amtszeit als Geschäftsführer2.1yrs
Eigentum des Geschäftsführers0.02%
Durchschnittliche Amtszeit des Managements2.5yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder9.5yrs

Jüngste Management Updates

Recent updates

Cencora (NYSE:COR) Is Increasing Its Dividend To $0.55

Nov 09
Cencora (NYSE:COR) Is Increasing Its Dividend To $0.55

Why We're Not Concerned About Cencora, Inc.'s (NYSE:COR) Share Price

Oct 31
Why We're Not Concerned About Cencora, Inc.'s (NYSE:COR) Share Price

Here's Why We Think Cencora (NYSE:COR) Is Well Worth Watching

Oct 10
Here's Why We Think Cencora (NYSE:COR) Is Well Worth Watching

Here's Why Cencora (NYSE:COR) Can Manage Its Debt Responsibly

Sep 18
Here's Why Cencora (NYSE:COR) Can Manage Its Debt Responsibly

Cencora: Credentials To Die For, But Underlying Issues Make Case For 'Hold' Rating

Sep 18

Market Participants Recognise Cencora, Inc.'s (NYSE:COR) Earnings

Jul 16
Market Participants Recognise Cencora, Inc.'s (NYSE:COR) Earnings

Cencora: Potential Exists, But Ambiguous Valuations And Data Breach Risks Are Concerning

Jun 30

Are Investors Undervaluing Cencora, Inc. (NYSE:COR) By 43%?

Jun 28
Are Investors Undervaluing Cencora, Inc. (NYSE:COR) By 43%?

Here's Why Cencora (NYSE:COR) Can Manage Its Debt Responsibly

Jun 09
Here's Why Cencora (NYSE:COR) Can Manage Its Debt Responsibly

Do Cencora's (NYSE:COR) Earnings Warrant Your Attention?

May 21
Do Cencora's (NYSE:COR) Earnings Warrant Your Attention?

Investors Interested In Cencora, Inc.'s (NYSE:COR) Earnings

Apr 05
Investors Interested In Cencora, Inc.'s (NYSE:COR) Earnings

Cencora Remains Chronically Undervalued, With Material Growth Potential

Mar 25

Cencora, Inc.'s (NYSE:COR) Intrinsic Value Is Potentially 53% Above Its Share Price

Mar 18
Cencora, Inc.'s (NYSE:COR) Intrinsic Value Is Potentially 53% Above Its Share Price

Cencora (NYSE:COR) Seems To Use Debt Quite Sensibly

Feb 25
Cencora (NYSE:COR) Seems To Use Debt Quite Sensibly

Cencora (NYSE:COR) Is Posting Promising Earnings But The Good News Doesn’t Stop There

Feb 07
Cencora (NYSE:COR) Is Posting Promising Earnings But The Good News Doesn’t Stop There

Cencora, Inc.'s (NYSE:COR) Business Is Yet to Catch Up With Its Share Price

Jan 05
Cencora, Inc.'s (NYSE:COR) Business Is Yet to Catch Up With Its Share Price

Cencora: Continued Economic Value On The Table Across All Investment Horizons

Jan 04

A Look At The Fair Value Of Cencora, Inc. (NYSE:COR)

Dec 15
A Look At The Fair Value Of Cencora, Inc. (NYSE:COR)

Cencora (NYSE:COR) Is Paying Out A Larger Dividend Than Last Year

Nov 05
Cencora (NYSE:COR) Is Paying Out A Larger Dividend Than Last Year

Is Cencora (NYSE:COR) A Risky Investment?

Nov 03
Is Cencora (NYSE:COR) A Risky Investment?

Cencora: New Name, Same Old Economic Leverage, Reiterate Buy

Oct 18

AmerisourceBergen Corporation (NYSE:ABC) Shares Could Be 34% Below Their Intrinsic Value Estimate

Aug 01
AmerisourceBergen Corporation (NYSE:ABC) Shares Could Be 34% Below Their Intrinsic Value Estimate

AmerisourceBergen: Great Company, Wrong Price (Rating Downgrade)

Jul 28

We Think AmerisourceBergen (NYSE:ABC) Can Stay On Top Of Its Debt

Jun 19
We Think AmerisourceBergen (NYSE:ABC) Can Stay On Top Of Its Debt

Is AmerisourceBergen Corporation (NYSE:ABC) Trading At A 28% Discount?

May 01
Is AmerisourceBergen Corporation (NYSE:ABC) Trading At A 28% Discount?

Here's Why We Think AmerisourceBergen (NYSE:ABC) Is Well Worth Watching

Apr 10
Here's Why We Think AmerisourceBergen (NYSE:ABC) Is Well Worth Watching

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Bob Mauch im Vergleich zu den Einnahmen von Cencora verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Sep 30 2024n/an/a

US$2b

Jun 30 2024n/an/a

US$2b

Mar 31 2024n/an/a

US$2b

Dec 31 2023n/an/a

US$2b

Sep 30 2023US$8mUS$975k

US$2b

Jun 30 2023n/an/a

US$2b

Mar 31 2023n/an/a

US$2b

Dec 31 2022n/an/a

US$2b

Sep 30 2022US$6mUS$850k

US$2b

Jun 30 2022n/an/a

US$2b

Mar 31 2022n/an/a

US$2b

Dec 31 2021n/an/a

US$2b

Sep 30 2021US$6mUS$800k

US$2b

Jun 30 2021n/an/a

-US$4b

Mar 31 2021n/an/a

-US$4b

Dec 31 2020n/an/a

-US$3b

Sep 30 2020US$4mUS$700k

-US$3b

Jun 30 2020n/an/a

US$2b

Mar 31 2020n/an/a

US$2b

Dec 31 2019n/an/a

US$649m

Sep 30 2019US$4mUS$675k

US$855m

Jun 30 2019n/an/a

US$956m

Mar 31 2019n/an/a

US$930m

Dec 31 2018n/an/a

US$1b

Sep 30 2018US$3mUS$675k

US$2b

Vergütung im Vergleich zum Markt: BobDie Gesamtvergütung ($USD7.70M) liegt unter dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt US ($USD12.73M).

Entschädigung vs. Einkommen: BobDie Bezüge der Mitarbeiter sind um mehr als 20 % gestiegen, während die Unternehmensgewinne im vergangenen Jahr um mehr als 20 % gesunken sind.

Geschäftsführer

Bob Mauch (57 yo)

2.1yrs

Amtszeit

US$7,697,850

Vergütung

Dr. Robert P. Mauch, PharmD, Ph D., also known as Bob, is an Executive Vice President at Cencora, Inc. (formerly known as AmerisourceBergen Corporation) since February 2015 and served as its Group Presiden...

Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Steven Collis
Executive Chairman13.5yrsUS$17.51m0.16%
$ 74.6m
Robert Mauch
President2.1yrsUS$7.70m0.016%
$ 7.6m
James Cleary
Executive VP & CFO6yrsUS$5.45m0.061%
$ 28.9m
Elizabeth Campbell
Executive VP & Chief Legal Officer3.2yrsUS$4.03m0.0060%
$ 2.8m
Lazarus Krikorian
Senior VP12.8yrskeine Daten0.012%
$ 5.5m
Pawan Verma
Executive VPless than a yearkeine Datenkeine Daten
Bennett Murphy
Senior Vice President of Investor Relationsno datakeine Datenkeine Daten
Jennifer Dubas
Senior VP & Chief Compliance Officerno datakeine Datenkeine Daten
Silvana Battaglia
Executive VP & Chief Human Resources Officer5.8yrsUS$3.48m0.0071%
$ 3.4m
Richard Tremonte
EVP & President of U.S. Pharmaceuticalsless than a yearkeine Datenkeine Daten
Ann Anaya
Senior VP and Chief Diversity Equity & Inclusion Officer2.8yrskeine Datenkeine Daten
Juan Guerra
EVP & President of International Business Groupless than a yearkeine Datenkeine Daten

2.5yrs

Durchschnittliche Betriebszugehörigkeit

57yo

Durchschnittliches Alter

Erfahrenes Management: CORDas Führungsteam des Unternehmens gilt als erfahren (2.5 Jahre durchschnittliche Betriebszugehörigkeit).

Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Steven Collis
Executive Chairman13.5yrsUS$17.51m0.16%
$ 74.6m
Robert Mauch
Presidentless than a yearUS$7.70m0.016%
$ 7.6m
Lauren Tyler
Independent Director1.1yrskeine Datenkeine Daten
Richard Gochnauer
Independent Director16.2yrsUS$300.10k0.011%
$ 5.5m
Mark M. Durcan
Lead Independent Director9.2yrsUS$380.05k0.010%
$ 4.8m
Lon Greenberg
Independent Director11.5yrsUS$332.60k0.0057%
$ 2.7m
Kathleen Hyle
Independent Director14.5yrsUS$320.10k0.011%
$ 5.1m
Dennis Nally
Independent Director4.8yrsUS$375.36k0.0052%
$ 2.5m
Ornella Barra
Director9.8yrskeine Datenkeine Daten
Henry McGee
Independent Director20yrsUS$320.10k0.0077%
$ 3.7m
Lorence Kim
Independent director2.1yrsUS$397.33k0.000090%
$ 42.9k
Redonda Miller
Independent Director1.8yrsUS$311.82k0.00080%
$ 381.4k

9.5yrs

Durchschnittliche Betriebszugehörigkeit

64yo

Durchschnittliches Alter

Erfahrener Vorstand: CORDie Vorstandsmitglieder gelten als erfahren (9.5 Jahre durchschnittliche Amtszeit).